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We focused on rates of malaria in the state of Amazo-
nas and city of Manaus, Brazil. Plasmodium vivax account-
ed for an increased number and rate of hospital admissions, 
while P. falciparum cases decreased. Our observations on 
malaria epidemiology suggest that the increased hospital-
ization rate could be due to increased severity of P. vivax 
infections.
T
he study of malaria prevalence in the state of Ama-
zonas and city of Manaus indicates an increase in the 
percentage of hospitalized Plasmodium vivax patients and 
an overall increase in malaria cases caused by this para-
site. Our observations on malaria epidemiology and case 
treatment suggest that the increased hospital admissions are 
associated with a higher frequency of severe disease as-
sociated with P. vivax infections. Amazonas includes most 
of the Brazilian Amazon Region, where malaria has been 
controlled but never eradicated. Since the 1980s, there has 
been a reemergence of malaria, which appears to coincide 
with changing malaria control policies associated with the 
ending of the Malaria Eradication Campaign (1,2). 
From January through August 2003, the number of cas-
es nationwide was reduced by 2.6%, when compared with 
the same period in 2002. However, this change did not rep-
resent a uniform reduction in the number of malaria infec-
tions within the country. The states of Amazonas, Rondô-
nia, and Tocantins reported increases of 82.9%, 14.7%, and 
10.3%, respectively (3). Perhaps the best indicator of what 
has been occurring with malaria control during the past 5 
years is reﬂ  ected in recent statistics for malaria in Ama-
zonas and the city of Manaus. During 2002 and 2003, the 
number of malaria cases reported in Amazonas increased 
103.3% (4).
An observational study conducted in the reference 
center for diagnosis and treatment of malaria in Amazo-
nas (Fundação de Medicina Tropical do Amazonas [FMT-
AM]) described severe disease, including thrombocytope-
nia with hemorrhagic manifestations during infection with 
P. vivax. In that series, 46 (61.3%) of 75 patients admitted 
to the hospital for treatment of P. vivax malaria were clas-
siﬁ  ed with severe disease using predetermined criteria (5). 
We considered increased case severity as the need to hos-
pitalize patients for treatment. Our primary goals were to 
present the epidemiology of malaria in Amazonas and the 
city of Manaus from 1980 to 2006 and to describe the over-
all rates, prevalence, and admission rates of malaria caused 
by P. falciparum and P. vivax.
The Study
We extracted total yearly cases of malaria and popula-
tion size in Amazonas from the database maintained by the 
Brazilian Ministry of Health (DATASUS, 2004), National 
Foundation of Health (6–8), and Secretary of Surveillance 
in Health (3,9). Data from FMT-AM were extracted from 
the malaria logbooks (for the years before the Foundation 
started publishing the reports) and from the Quarterly re-
ports (for the years that the Foundation published the re-
ports). All malaria cases diagnosed and referred for treat-
ment are maintained (1989–1994) and quarterly reports are 
published by the FMT-AM (10). Quarterly reports pub-
lished from 1995 to 2004 provided the total number of ma-
laria diagnoses, case-patients admitted to the hospital, and 
number of deaths. Data from 2005 and 2006 were obtained 
by one of the authors (M.R.F. Costa) directly at FMT-AM 
(Subgerência de Arquivos Médicos e Contas Hospitalares).
The hospital protocol is to exclude mixed infections by ad-
ditional testing. We collected and tabulated data from these 
sources by year, parasite species, admissions, and percent 
admissions (Table). Percent admission was calculated as 
the total number of case-patients admitted to the hospital 
due to the speciﬁ  ed parasite, divided by the total number 
of malaria cases caused by that same parasite in FMT-AM 
during that year, multiplied by 100. 
Malaria cases from all causes in Amazonas, 1980–
2006, are presented in Figure 1. An irregular increase is 
noted since 1988, reaching a peak in 1999, followed by a 
decline in 2001, only to rise again in the following years. 
A decrease was observed in 2006, but the data are not ﬁ  -
nal. Figure 1 also shows the total number of malaria cases 
diagnosed at FMT-AM; ﬂ  uctuations observed are very 
similar in direction and relative magnitude to those found 
statewide. 
The number of infections due to P. falciparum and 
P. vivax diagnosed annually at FMT-AM are shown in 
Figure 2, panel A. The percentage of diagnosed case-pa-
tients admitted to the hospital, by parasite and year, is 
presented in Figure 2, panel B. In 1989, 264 (20%) of 
the patients with a diagnosis of P. falciparum infection 
were admitted to the hospital, while only 26 (0.85%) of 
those infected with P. vivax required admission. While P. 
falciparum remains the main cause of malaria admissions, 
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we observed a signiﬁ  cant increase in P. vivax admissions: 
the mean percent admissions from 1989 to 1996 was 0.59% 
(standard deviation [SD] 0.18), increasing to 1.91% (SD 
0.74) from 1997 to 2006. This relative increase in P. vivax 
malaria requiring admission to the hospital for treatment 
was disproportionate to the change in numbers of cases and 
to the relative frequency of P. vivax cases over P. falci-
parum malaria cases.
Conclusions
We presented the epidemiology of recent malaria cas-
es in the State of Amazonas and city of Manaus, empha-
sizing the emergence of severe P. vivax malaria. Assum-
ing that patients requiring hospital admission were sicker 
than those treated as outpatients, we observed that malaria 
transmission in this region was continuous and ﬂ  uctuated 
in intensity. P. vivax was consistently the main cause of 
malaria, but the number of patients with P. vivax requiring 
hospital admission increased signiﬁ  cantly in recent years. 
Changes in control operations were linked to the reestab-
lishment of malaria in major urban areas of the Amazon 
basin, e.g., Belém (11). In Manaus, this could have had an 
impact on P. vivax disease manifestations and severity but 
did not seem to have affected the severity of disease caused 
by P. falciparum, perhaps because the current policy of 
early diagnosis and treatment has been reported to have a 
greater impact on disease caused by P. falciparum than P. 
vivax (12,13).
In this study, we assumed that case deﬁ  nition and cri-
teria for admission at FMT-AM, for both P. vivax and P. 
falciparum malaria, were relatively constant (http://www.
fmt.am.gov.br/). Our data showed that the likelihood of 
hospital admissions for case-patients diagnosed with P. 
vivax malaria increased substantially after 1996, while the 
percentage of P. falciparum admissions declined. The de-
creasing rate of admission for P. falciparum malaria during 
the later years of our study supports the interpretation that 
the criteria for admission to FMT-AM were not loosened. It 
is possible that referrals to FMT-AM from elsewhere in the 
region increased during this period, but that would likely 
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Table. Total malaria cases in the state of Amazonas, Brazil, 1980–2006, and malaria case-patients diagnosed and admitted at FMT-
AM by parasite, 1989–2006 * 
FMT–AM
Plasmodium falciparum  P. vivax Other causes‡ 
Year Amazonas†
Malaria, all 
causes
No. case-
patients
No. admitted
(%)
No. case-
patients
No. admitted 
(%)
No. case-
patients
1980 4,447  –   –   –   –  –  – 
1981 8,169  –   –   –   –  –  – 
1982 13,142  –   –   –  –  –  – 
1983 10,299  –   –   –   –  –  – 
1984 8,528  –   –   –  – –  – 
1985 11,196  –   –   –   –  –  – 
1986 15,319  –   –   –   –  –  – 
1987 15,233  –   –   –   –  –  – 
1988 19,392  –   –   –   –  –  – 
1989 34,944 4,347 1,262 264 (20.92)  3,043 26 (0.85)  42
1990 28,479 3,037 839 175 (20.86)  2,175 15 (0.69)  23
1991 45,849 5,765 664 179 (26.96)  5,076 23 (0.45)  25
1992 37,885 5,083 670 118 (17.61)  4,398 29 (0.66)  15
1993 55,364 10,157 2,834 325 (11.47)  7,284 24 (0.33)  39
1994 68,287 7,469 1,433 199 (13.89)  5,948 44 (0.74)  88
1995 52,602 5,765 1,049 174 (16.59)  4,518 30 (0.66)  198
1996 70,044 6,206 1,333 201 (15.08)  4,686 18 (0.38)  187
1997 94,382 10,483 1,871 186 (9.78)  8,506 175 (2.06)  106
1998 114,748 10,854 1,751 217 (12.39)  9,004 116 (1.29)  99
1999 167,722 19,967 4,459 341 (7.65)  15,238 155 (1.02)  270
2000 96,026 12,266 2,541 177 (6.97)  9,227 147 (1.59)  498
2001 48,385 4,315 813 127 (15.62)  3,443 95 (2.76)  59
2002 70,223 88,711 992 106 (10.69)  7,808 263 (3.37)  71
2003 143,343 30,017 2,213 150 (6.78)  27,679 677 (2.45)  125
2004 152,440 27,169 5,727 257 (4.49)  21,228 345 (1.63)  214
2005 229,330 31,243 8,698 264 (3.52)  22,174 378 (1.70)  371
2006 190,378 16,182 3,363 175 (4.31)  12,672 161 (1.27)  147
*2005–2006 data obtained at the Malaria Laboratory and Epidemiology Department of the FMT–AM by M.R.F.C. FMT-AM, Fundação de Medicina 
Tropical do Amazonas; –, data not available. 
†Total malaria cases in the state of Amazonas. 
‡Includes P. malariae infections and mixed infections (P. falciparum + P. vivax). Malaria Diagnosis and Hospitalization Trends, Brazil
affect P. falciparum admissions too. Based on these consid-
erations, we interpret the data as suggestive of an increased 
illness associated with P. vivax infections in the region. 
In this study we did not attempt to describe the speciﬁ  c 
disease manifestations that were the basis for admissions 
of individual patients. However, recent reports described a 
range of unusual manifestations of P. vivax infection else-
where (14), consistent with the disease manifestations re-
ported in Manaus (5).
Biologic aspects of the human host, vector, and para-
site and changes in the environment contribute to the epide-
miology of malaria. Our data demonstrate that malaria is a 
growing health burden in the Amazon Region of Brazil and 
that disease caused by P. vivax is a substantial and increas-
ing threat to the health of the population in Manaus. More 
studies are needed to understand the complex mechanisms 
of this disease and its impact on susceptible populations.
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Figure 1. Malaria diagnoses (in thousands) 
according to blood smears positive for Plasmodium 
falciparum or P. vivax in Amazonas, Brazil, (open 
squares) and Fundação de Medicina Tropical do 
Amazonas (FMT-AM) (solid triangles), 1980–2006.
Figure 2. Malaria diagnoses by parasite species, Plasmodium 
falciparum (solid circles) and P. vivax (open circles), at the Fundação 
de Medicina Tropical do Amazonas (FMT-AM), Amazonas, Brazil, 
1989–2006. A) Total numbers of diagnoses (in thousands). 
B) Percentage of infections resulting in hospital admission.DISPATCHES
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